Healthcare Patient Consent Form for Lisdexamfetamine

Healthcare Patient Consent Form for Lisdexamfetamine

Document Analysis (Administrative)

This document is a patient-specific informed consent and authorization for treatment using lisdexamfetamine. A complete, lawful consent includes: patient identification and contact information; relevant medical and psychiatric history; medication-specific disclosures (indications, risks, benefits, contraindications, interactions); alternatives to treatment; patient acknowledgments and certifications; HIPAA/privacy authorization for release of protected health information related to this medication; and an expiration or review date for the authorization. Only the patient or a legally authorized representative signs this form.

Standard legal language is included to document that the patient: received an explanation of expected benefits and material risks, understands alternatives and right to refuse or withdraw consent, and authorizes the clinician to prescribe and manage lisdexamfetamine. The form records baseline health and medication history relevant to stimulant therapy and requires affirmative acknowledgement of warnings regarding cardiovascular, psychiatric, and substance-use risks.

Patient Information

Patient Name:

Male Female Other / Prefer to describe:

Insurance Information

Medical & Psychiatric History

Baseline weight (lbs):    Height (inches):

Are you pregnant, trying to become pregnant, or breastfeeding? Yes No If yes, explain:

Medication-Specific Information: Lisdexamfetamine

Indication for treatment:

Risks, Benefits, and Alternatives

Risks: Lisdexamfetamine is a central nervous system stimulant. Material risks include, but are not limited to: increased heart rate and blood pressure; palpitations; chest pain; arrhythmia; elevation in blood pressure; insomnia; decreased appetite and weight loss; abdominal pain; headache; nervousness; anxiety; potential for new or worsened psychiatric symptoms including agitation, mania, psychosis, or suicidal ideation; potential for dependence, misuse, or diversion; rare cardiovascular events including stroke, myocardial infarction, or sudden death in patients with predisposing cardiac conditions. There are also risks of drug interactions, particularly with monoamine oxidase inhibitors and certain antidepressants.

Benefits: Potential benefits include improved attention, reduced impulsivity and hyperactivity, and improved daily functioning in the indicated disorder. The prescriber will assess clinical response and adjust treatment as necessary.

Alternatives: Non-stimulant pharmacotherapy, behavioral therapy, psychotherapy, educational and occupational accommodations, or no pharmacologic treatment are reasonable alternatives depending on clinical circumstances. The patient has the right to discuss these alternatives and to refuse treatment.

Contraindications, Warnings, and Monitoring

The patient certifies that they have informed the prescriber of any history of cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, severe anxiety, agitation, history of psychosis, or substance use disorder. Lisdexamfetamine is contraindicated with concurrent or recent use of monoamine oxidase inhibitors. The prescriber will monitor vital signs, weight, psychiatric status, and potential adverse effects at follow-up visits. The patient must seek immediate care for chest pain, syncope, sudden shortness of breath, or new severe psychiatric symptoms.

Authorization, Acknowledgment, and Consent

By signing below, I acknowledge that the prescriber has explained the nature of the proposed treatment with lisdexamfetamine, the intended benefits, the material risks and likely complications, reasonable alternatives (including non-treatment), and the right to refuse or withdraw consent at any time. I have had the opportunity to ask questions and those questions have been answered to my satisfaction. I understand that no guarantee can be made concerning the results of treatment.

I further authorize the prescribing clinician and clinic staff to disclose and obtain protected health information as necessary for purposes of treatment, billing, and coordination of care related to this medication. This authorization includes communication with pharmacies, other treating clinicians, and insurance payors as required for safe prescribing and monitoring.

Patient Certifications

I certify that the information I have provided on this form is true and complete to the best of my knowledge. I understand that willful misrepresentation of medical history or substance use may affect the safety of this medication and may result in discontinuation of therapy.

I understand I may revoke this authorization at any time by submitting a written request to the clinic; such revocation will not affect actions already taken in reliance on this authorization prior to receipt of the revocation.

Patient Questions and Declinations

Yes No

Prescriber / Clinical Notes (For Office Use)

Sign Now